Dendritic cells loaded with FK506 kill T cells in an antigen-specific manner and prevent autoimmunity in vivo

eLife

Volumn 2013, Issue 2, 2013, Pages

  Orange, Dana E ^a,b   Blachere, Nathalie E ^a   Fak, John ^a   Parveen, Salina ^a   Frank, Mayu O ^a   Herre, Margo ^a   Tian, Suyan ^a   Monette, Sebastien ^c   Darnell, Robert B ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CALCINEURIN INHIBITOR; COLLAGEN TYPE 2; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ANIMAL; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNITY; CELL CULTURE; COCULTURE; DBA MOUSE; DENDRITIC CELL; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; PATHOLOGY; T LYMPHOCYTE; TIME; TRANSPLANTATION;

ANIMALS; ANTIGENS; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNITY; CALCINEURIN INHIBITORS; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN TYPE II; DENDRITIC CELLS; DIFFUSION; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MALE; MICE, INBRED DBA; T-LYMPHOCYTES; TACROLIMUS; TIME FACTORS;

EID: 84879062149     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.00105     Document Type: Article

References (31)

1. Akbar AN, Borthwick NJ, Wickremasinghe RG, Panayoitidis P, Pilling D, Bofill M, et al. 1996. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol 26:294-9.
2. Albert ML, Sauter B, Bhardwaj N. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-9.
3. Bendele A, McComb J, Gould T, McAbee T, Sennello G, Chlipala E, et al. 1999. Animal models of arthritis: relevance to human disease. Toxicol Pathol 27:134-42.
4. Bierer BE, Mattila PS, Standaert RF, Herzenberg LA, Burakoff SJ, Crabtree G, et al. 1990. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci USA 87:9231-5.
5. Brand DD, Latham KA, Rosloniec EF. 2007. Collagen-induced arthritis. Nat Protoc 2:1269-75.
6. Clark RL, Cuttino JTJ, Anderle SK, Cromartie WJ, Schwab JH. 1979. Radiologic analysis of arthritis in rats after systemic injection of streptococcal cell walls. Arthritis Rheum 22:25-35.
7. Doi R, Tangoku A, Inoue K, Chowdhury P, Rayford PL. 1992. Effects of FK506 on exocrine pancreas in rats. Pancreas 7:197-204.
8. Dumont FJ, Kastner C, Iacovone FJ, Fischer PA. 1994. Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes. J Pharmacol Exp Ther 268:32-41.
9. Duperrier K, Velten FW, Bohlender J, Demory A, Metharom P, Goerdt S. 2005. Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes. Mol Immunol 42:1531-40.
10. Eiras G, Imventarza O, Murase N, Ueda Y, Todo S, Starzl T, et al. 1990. Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506. Transplantation 49:1170-2.
11. Hackstein H, Thomson AW. 2004. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4:24-34.
12. Horigome A, Hirano T, Oka K. 1998. Tacrolimus-induced apoptosis and its prevention by interleukins in mitogen-activated human peripheral-blood mononuclear cells. Immunopharmacology 39:21-30.
13. Hildeman DA, Zhu Y, Mitchell TC, Bouillet P, Strasser A, Kappler J, et al. 2002. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16:759-67.
14. Inaba K, Swiggard WJ, Steinman RM, Romani N, Schuler G. 2001. Isolation of dendritic cells. Curr Protoc Immunol Chapter 3, Unit 3.7, p. 1-15.
15. Ito T, Kimura T, Furukawa M, Yamaguchi H, Goto M, Nakano I, et al. 1994. Protective effects of gabexate mesilate on acute pancreatitis induced by tacrolimus (FK-506) in rats in which the pancreas was stimulated by caerulein. J Gastroenterol 29:305-13.
16. Lee YR, Yang IH, Lee YH, Im SA, Song S, Li H, et al. 2005. Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. Blood 105:3951-5.
17. Lenardo MJ. 1991. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353:858-61.
18. Longman RS, Braun D, Pellegrini S, Rice CM, Darnell RB, Albert ML. 2007. Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation. Blood 109:1113-22.
19. Migita K, Eguchi K, Kawabe Y, Tsukada T, Mizokami A, Nagataki S. 1995. FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. J Clin Invest 96:727-32.
20. Migita K, Eguchi K, Kawabe Y, Origuchi T, Tominaga M, Nagataki S. 1997. FK506 potentiates steroid-induced T-cell apoptosis. Transplantation 64:1365-9.
21. Migita K, Origuchi T, Kawabe Y, Tominaga M, Ida H, Kawakami A, et al. 1999. FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL. Transplantation 68:1018-23.
22. Orange DE, Jegathesan M, Blachere NE, Frank MO, Scher HI, Albert ML, et al. 2004. Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy. Prostate Cancer Prostatic Dis 7:63-72.
23. Popov I, Li M, Zheng X, San H, Zhang X, Ichim TE, et al. 2006. Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine. Arthritis Res Ther 8:R141.
24. Sabado RL, Bhardwaj N. 2010. Directing dendritic cell immunotherapy towards successful cancer treatment. Immunotherapy 2:37-56.
25. Siekierka JJ, Hung SH, Poe M, Lin CS, Sigal NH. 1989a. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 341:755-7.
26. Siekierka JJ, Staruch MJ, Hung SH, Sigal NH. 1989b. FK-506, a potent novel immunosuppressive agent, binds to a cytosolic protein which is distinct from the cyclosporin A-binding protein, cyclophilin. J Immunol 143:1580-3.
27. Szabo G, Gavala C, Mandrekar P. 2001. Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells. J Investig Med 49:442-9.
28. Takagishi K, Yamamoto M, Nishimura A, Yamasaki G, Kanazawa N, Hotokebuchi T, et al. 1989. Effects of FK-506 on collagen arthritis in mice. Transplant Proc 21:1053-5.
29. Turnquist HR, Raimondi G, Zahorchak AF, Fischer RT, Wang Z, Thomson AW. 2007. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J Immunol 178:7018-31.
30. Vanier LE, Prud'homme GJ. 1992. Cyclosporin A markedly enhances superantigen-induced peripheral T cell deletion and inhibits anergy induction. J Exp Med 176:37-46.
31. Woltman AM, de Fijter JW, Kamerling SW, Paul LC, Daha MR, van Kooten C. 2000. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 30:1807-12.